Aviso Wealth Management lifted its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 42.7% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 10,661 shares of the financial services provider’s stock after acquiring an additional 3,191 shares during the period. CME Group accounts for 1.3% of Aviso Wealth Management’s portfolio, making the stock its 13th largest position. Aviso Wealth Management’s holdings in CME Group were worth $2,352,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently made changes to their positions in CME. Y.D. More Investments Ltd acquired a new position in CME Group during the 2nd quarter valued at about $36,000. McClarren Financial Advisors Inc. increased its holdings in shares of CME Group by 66.1% in the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. Asset Dedication LLC increased its holdings in shares of CME Group by 515.2% in the second quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares during the period. Finally, Bank & Trust Co acquired a new position in shares of CME Group in the second quarter valued at about $76,000. 87.75% of the stock is owned by institutional investors.
Insider Activity
In other news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now directly owns 25,067 shares of the company’s stock, valued at approximately $5,587,935.64. This represents a 1.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 5.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 15,621 shares of company stock valued at $3,441,063. Insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
View Our Latest Research Report on CME
CME Group Price Performance
NASDAQ:CME opened at $225.28 on Monday. The stock has a 50 day moving average price of $222.62 and a 200 day moving average price of $210.39. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $81.18 billion, a PE ratio of 23.69, a P/E/G ratio of 5.20 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36.
CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period in the previous year, the firm posted $2.25 earnings per share. The company’s revenue was up 18.4% on a year-over-year basis. Equities research analysts expect that CME Group Inc. will post 10.22 EPS for the current fiscal year.
CME Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Monday, December 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.04%. CME Group’s dividend payout ratio is currently 48.37%.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Plug Power Stock: Mixed Results Adds To Volatilty
- Conference Calls and Individual Investors
- 2 Cybersecurity Stocks to Buy and Hold for 2025
- About the Markup Calculator
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.